Biotech · Private company
Invectys
Track this companyFree. Adds Invectys to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- INVAC-1Phase 2 · Leukemia, Lymphocytic, Chronic, B-CellClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 21, 2023ClinicalTrials.gov NCT05672459 · fetched Nov 12, 2026
- DNA Plasmid Encoding a Modified Human Telomerase Reverse Transcriptase (hTERT), Invac-1 in Chronic Lymphocytic LeukemiaPHASE2 · TERMINATED · started Jul 25, 2018ClinicalTrials.gov NCT03265717 · fetched Nov 12, 2026